January 3, 2006
 |
Balls of ice form around hollow needles filled with pressurized argon gas in a demonstration of how the needles freeze the prostate gland and cancerous cells inside it for cancer
treatment. Mail Tribune / Bob Pennell
|
ADVANCING CARE
Sophisticated new tools make cryotherapy, a prostate-cancer treatment, less invasive
By BILL KETTLER
Mail Tribune
Physicians have been freezing prostate tumors since the 1960s, but the results often left something to be desired.
Below-zero temperatures destroyed cancer cells as the prostate froze, but physicians lacked the ability to contain the cold within the walnut-sized gland. Men often came out of the procedure with
damage to sensitive surrounding tissues the urethra, the rectum and the urinary sphincter.
Side effects like those made patients and physicians alike wary of cryotherapy, but new technology has made it a much more sensitive tool. Physicians now use computers and ultrasound monitors to map
the prostate and position the needles that freeze it. Sophisticated temperature monitors are placed in adjacent tissues and a warming catheter inserted in the urethra to minimize side effects.
"The computer-generated map tells us where to insert the needles," says Dr. Eric Martin, a urologist who does "cryoablation" of the prostate at Providence Medford Medical Center.
"We can fine-tune where all these things are going to go."
Martin says freezing the gland is a much less invasive procedure than removing it surgically. Its also quick. A procedure usually takes about two hours, and men can typically go home the same day
they enter the hospital.
"Most people dont find it painful," Martin says.
Cryoablation involves little of the drama or blood most people associate with surgery. After a patient is anesthetized, an ultrasound monitor is inserted in the rectum. Sound waves are
fed to a computer, which draws a map of the prostate on a screen. The computer determines where to insert two sets of needles. One group of six carries pressurized argon gas that freezes the gland; six
more monitor the temperature of surrounding tissues.
A grid plate helps Martin insert each needle in the appropriate position, and ultrasound pictures of the gland let him check them for proper placement.
When everything is ready, the argon gas is fed into the freezing needles. The gas cools rapidly as it expands, creating a ball of frozen tissue around the end of each needle.
Martin monitors the size of each "iceball" by looking at images of the prostate produced by the ultrasound monitor. Saline solution pumped through the warming catheter prevents the urethra
from freezing.
The gland is frozen to minus 40 degrees Celcius, thawed (by pumping helium gas through the freezing needles), refrozen and thawed once more. Martin says the two freezing cycles ensure that the gland
and the cancer cells inside it are destroyed.
While freezing the prostate is less invasive than surgery, physicians usually limit it to men who are already impotent or are not interested in maintaining their potency. Thats because
cryotherapy often destroys the blood vessels that are associated with erection.
Men who want to preserve their potency usually choose to treat their cancer surgically or with radiation, which have fewer erectile side effects.
Cryotherapy is also reserved mostly for cancer that is still localized within the gland and for men who whose prostate cancer returned after other treatments (such as radiation).
"Its the gold standard treatment for men with recurrent cancer in the prostate," Martin says.
Patients like the procedure because its fast and relatively painless.
"I had a little tenderness in the bottom. That was about it," said Neil Watson of Medford, who underwent cryoablation in November.
Like most patients, Watson, 66, also had to wear a urinary catheter for about two weeks, but he says he was "back to normal within about two days after it was removed."
Martin says the procedure is a good example of "an old idea thats been improved to make it safe and effective."
Reach reporter Bill Kettler at 776-4492, or e-mail
bkettler@mailtribune.com.
About prostate cancer
Prostate cancer is the most commonly diagnosed cancer in American men and the second-leading cause of cancer deaths. The medical journal Contemporary Urology estimates there were about 230,000
cases of prostate cancer diagnosed in 2004 and about 29,900 men died from the disease.
One in eight men will develop prostate cancer sometime during his lifetime. Physicians can often detect prostate cancer early by noting changes in the size of the gland. They recommend all men
have regular digital prostate exams by age 50.
Physicians still dont know much about the origins of prostate cancer. Diet apparently plays a factor. Its rare in areas of the world where men eat a low-fat diet (Asia and the Pacific
Islands) and more widespread where men eat more fat.